Category: colorectal cancer

Universal Screening for Lynch Syndrome: Can Tumor Sequencing Have a Larger Public Health Impact on Treatment and Prevention of Colorectal Cancer?

Universal Screening with an arrow labeled Lynch Syndrome and DNA below it

Lynch syndrome (LS) is the most common hereditary syndrome associated with increased risk of colorectal cancer (CRC), accounting for about 3% of CRC patients. LS is a dominantly inherited condition with mutations in several mismatch repair (MMR) genes. Persons with LS are also at increased risk for endometrial and other cancers. Lynch syndrome affects 1 Read More >

May 9, 2018 by Muin J. Khoury, Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, and Heather Hampel, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio

genomics, screening

colorectal cancer, Lynch Syndrome, universal screening

Making Universal Screening for Lynch Syndrome a Reality: The Lynch Syndrome Screening Network

Every day, about 400 people in the United States are diagnosed with colorectal cancer. Approximately twelve of them have Lynch syndrome, a hereditary condition that increases the risk of colorectal cancer and other cancers. Identifying people with Lynch syndrome could have substantial health benefits for them, their families, and communities. Read More >

March 22, 2012 by Deb Duquette, MS, CGC & Sarah Mange, MPH- Michigan Department of Community Health; Cecelia Bellcross, PhD, MS- Emory University; Heather Hampel, MS, CGC- The Ohio State University; Kory Jasperson, MS, CGC- Huntsman Cancer Institute (Authors are all from the Lynch Syndrome Screening Network (LSSN) Founding Board of Directors)1 Comment

colorectal cancer, genomics

colorectal cancer, family history, genetic testing, genetics, genomics, Lynch Syndrome